Terlipressin Acetate
Terlipressin, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation/re-oxygenation (OGD/R) -induced damage in intestinal epithelial cells (IEC-6) .Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.
Product Specifications
CAS Number
1884420-36-3
Product Name Alternative
Terlipressin diacetate anhydrous | Terlipressin acetate anhydrous
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
DMSO:95mg/mL (70.50mM)
Smiles
O=C ([C@H] (CSSC[C@@H] (C (N[C@H] (C1=O) CC2=CC=C (O) C=C2) =O) NC (CNC (CNC (CN) =O) =O) =O) NC ([C@@H] (NC ([C@@H] (NC ([C@] (N1) ([H]) CC3=CC=CC=C3) =O) CCC (N) =O) =O) CC (N) =O) =O) N (CCC4) [C@@H]4C (N[C@@H] (CCCCN) C (NCC (N) =O) =O) =O.CC (O) =O.CC (O) =O
Molecular Formula
C56H82N16O19S2
Molecular Weight
1347.5
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog